XML 77 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation and Capital Stock - Summary of Change in Stock-Based Award Activity (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Sep. 30, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Outstanding, ending balance (in shares) 900,000 900,000
Stock options    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Outstanding, beginning balance (in shares)   873,895
Granted (in shares)   158,620
Exercised/vested (in shares)   (131,800)
Expired (in shares)   0
Forfeited (in shares)   (3,696)
Outstanding, ending balance (in shares) 897,019 897,019
Options exercisable, ending balance (in shares) 557,664 557,664
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Beginning balance - weighted average exercise price (in dollars per share) | $ / shares   $ 61.69
Granted - weighted average exercise price (in dollars per share) | $ / shares   91.28
Exercised/vested - weighted average exercise price (in dollars per share) | $ / shares   50.82
Expired - weighted average exercise price (in dollars per share) | $ / shares   0
Forfeited - weighted average exercise price (in dollars per share) | $ / shares   91.28
Ending balance - weighted average exercise price (in dollars per share) | $ / shares $ 68.40 68.40
Options exercisable, ending balance - weighted average exercise price (in dollars per share) | $ / shares $ 58.71 $ 58.71
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward]    
Weighted average remaining contractual term - outstanding, ending balance   2 years 6 months
Weighted average remaining contractual term - options exercisable, ending balance   2 years 6 months
Restricted stock    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Outstanding, beginning balance (in shares)   312,097
Granted (in shares)   155,269
Exercised/vested (in shares)   (120,052)
Forfeited (in shares)   (36,860)
Outstanding, ending balance (in shares) 310,454 310,454
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares   $ 75.23
Granted - weighted average grant date fair value (in dollars per share) | $ / shares   89.91
Exercised/vested - weighted average grant date fair value (in dollars per share) | $ / shares   69.40
Forfeited - weighted average grant date fair value (in dollars per share) | $ / shares   81.98
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 84.03 $ 84.03
Performance Vested Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Outstanding, beginning balance (in shares)   330,716
Granted (in shares)   170,471
Performance-based leveraging (in shares) 30,116 30,116
Exercised/vested (in shares)   (176,471)
Expired (in shares)   (16,117)
Forfeited (in shares)   (16,963)
Outstanding, ending balance (in shares) 321,752 321,752
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares   $ 70.03
Granted - weighted average grant date fair value (in dollars per share) | $ / shares   134.26
Performance-based leveraging - weighted average grant date fair value (in dollars per share) | $ / shares   61.31
Exercised/vested - weighted average grant date fair value (in dollars per share) | $ / shares   58.68
Expired - weighted average grant date fair value (in dollars per share) | $ / shares   60.50
Forfeited - weighted average grant date fair value (in dollars per share) | $ / shares   82.25
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 109.25 $ 109.25